301363.SHE MeHow Innovative Ltd. A
- Market cap
- CNY 13.1B
- P/E
- 44.6x
- P/B
- 3.63x
- ROE
- 8.2%
- Dividend yield
- 0.65%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301363.SHE undervalued?
Graham number301363.SHE trades 168.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MeHow Innovative Ltd. A fundamental analysis
No fundamental analysis for MeHow Innovative Ltd. A yet.
MeHow Innovative Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MeHow Innovative Ltd. A
MeHow Innovative Ltd. designs, develops, manufactures, and sells precision medical device components and products in China and internationally. The company provides home ventilators, precision molds and automation equipment, surgical instruments, etc. It also offers variable dose pen, auto injector, auto secure dose pen; microfluidic solutions and laboratory consumables, such as cuvette, PCR tube, 96-well plates, freezing tubes, culture dish and bottle, suction head, and vac…
Full company profileMeHow Innovative Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MeHow Innovative Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 888M | 1.14B | 1.42B | 1.34B | 1.59B | 1.63B | 1.82B |
| Gross Profit | 444M | 511M | 609M | 551M | 671M | 652M | 746M |
| Operating Income | 319M | 367M | 409M | 304M | 372M | 339M | 422M |
| EBITDA | - | - | 532M | 440M | 509M | 432M | 363M |
| Net Income | 258M | 310M | 402M | 313M | 364M | 283M | 312M |
| EPS | 0.71 | 0.61 | 0.50 | 0.77 | 0.89 | 0.50 | 0.39 |
| Balance Sheet | |||||||
| Total Assets | 1.40B | 1.90B | 3.39B | 3.52B | 3.92B | 4.23B | 4.33B |
| Total Liabilities | 234M | 509M | 367M | 341M | 442M | 500M | 547M |
| Shareholders' Equity | 1.17B | 1.39B | 3.02B | 3.18B | 3.48B | 3.73B | 3.78B |
| Cash & Short-term Investments | 533M | 420M | 1.23B | 1.71B | 1.25B | 1.45B | 1.60B |
| Cash Flow | |||||||
| Operating Cash Flow | 303M | 196M | 381M | 351M | 448M | 352M | - |
| Capital Expenditure | 239M | 316M | 201M | 259M | 363M | 462M | 190M |
| Free Cash Flow | 63.2M | -120M | 180M | 91.6M | 85.1M | -110M | 158M |
| Ratios | |||||||
| ROE | 22.1% | 22.3% | 13.3% | 9.8% | 10.5% | 7.6% | 8.2% |
| ROA | 18.4% | 16.3% | 11.9% | 8.9% | 9.3% | 6.7% | 7.2% |
| Net Profit Margin | 29.1% | 27.3% | 28.4% | 23.4% | 22.8% | 17.4% | 17.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MeHow Innovative Ltd. A dividends
- Dividend yield
- 0.65%
- Forward dividend
- 0.26 CNY
- Payout ratio
- 30.0%
- Ex-dividend date
- Jun 12, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 84.8M | 0.15 | 30.0% |
| 2024 | CNY 64.8M | 0.16 | 17.8% |
| 2023 | CNY 143M | 0.35 | 45.5% |
| 2022 | CNY 6.25M | 0.01 | 1.6% |
| 2021 | CNY 73.7M | 0.15 | 23.8% |
| 2020 | CNY 58.4M | 0.16 | 22.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jun 12, 2026.
Who owns MeHow Innovative Ltd. A
- Insiders 70.75%
- Institutions 3.15%
- Public & others 26.11%
- Shares outstanding 796M
- Free float 229M
MeHow Innovative Ltd. A company profile
- Company name
- MeHow Innovative Ltd. A
- Ticker
- 301363.SHE
- ISIN
- CNE100005WP6
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2,608
- Fiscal year end
- December
- Address
- Building B, Shenzhen, China, 518116
- Phone
- 86 755 8305 1518
- Website
- mehow.com
About MeHow Innovative Ltd. A
MeHow Innovative Ltd. designs, develops, manufactures, and sells precision medical device components and products in China and internationally. The company provides home ventilators, precision molds and automation equipment, surgical instruments, etc. It also offers variable dose pen, auto injector, auto secure dose pen; microfluidic solutions and laboratory consumables, such as cuvette, PCR tube, 96-well plates, freezing tubes, culture dish and bottle, suction head, and vacutainer; cardiovascular products, including electrophysiology, and ablation catheter, high density mapping catheter, and intracardiac echocardiography solutions; surgical solutions, such as ultrasonic scalpels, staplers, ligating clips, sterile-grade/implant-grade injection components, micro precision equipment components, automated assembly, and others. In addition, the company offers ophthalmology and ENT consumables, phacoemulsification disposables, IOL delivery systems, and hearing aids and cochlear implants; respiratory testing equipment and consumables, ventilator consumables, pulmonary function testers, and disposable filters; eternal nutrition infusion sets, nasogastric tube and stoma tube, neuromodulation medical devices, and female reproductive health products; baby and maternity products, consumer electronics, drinking water bottles, personal care, etc. Mehow Innovative Ltd. was founded in 2010 and is headquartered in Shenzhen, China.
MeHow Innovative Ltd. A management
5- Ms. Jun'e YanCFO & Deputy GM · born 1977
- Ms. Jingxia TanSecretary of Board of Directors · born 1984
- Mr. Qifeng ChiDeputy General Manager · born 1978
- Mr. Bo YanDeputy General Manager · born 1981
- Juan ZhuAccounting Supervisor